Non-Invasive Biomarkers vs Liver Biopsy in Diagnosing & Staging NAFLD-Advanced Research in Gastroenterology & Hepatology-Juniper Publishers
JUNIPER PUBLISHERS- Advanced Research in Gastroenterology & Hepatology NON-INVASIVE BIOMARKERS VS LIVER BIOPSY IN DIAGNOSING & STAGING NAFLD Authored by Parveen Malhotra Introduction: Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of disease ranging from simple steatosis to inflammatory steatohepatitis (NASH) with increasing levels of fibrosis and ultimately cirrhosis. It has been considered the most common liver disease and the most frequent cause of elevated aminotransferases and cryptogenic cirrhosis. Aims and Objectives: To evaluate the role of non invasive biomarkers and compare them with liver biopsy in diagnosis and staging of Non Alcoholic Fatty Liver Disease Material and Methods: This study was conducted at Pt. B D Sharma, PGIMS, Rohtak. A total of forty consecutive patients of nonalcoholic fatty liver disease underwent liver biopsy, in addition to non-invasive biomarkers. P value of < 0.05 was taken as significant and <...